These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33854767)

  • 1. Association of daily physical activity with psychosocial aspects and functional capacity in patients with pulmonary arterial hypertension: a cross-sectional study.
    Nakazato L; Mendes F; Paschoal IA; Oliveira DC; Moreira MM; Pereira MC
    Pulm Circ; 2021; 11(2):2045894021999955. PubMed ID: 33854767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP).
    Stollfuss B; Richter M; Drömann D; Klose H; Schwaiblmair M; Gruenig E; Ewert R; Kirchner MC; Kleinjung F; Irrgang V; Mueller C
    J Med Internet Res; 2021 Oct; 23(10):e25163. PubMed ID: 34623313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical Activity and Its Association with Traditional Outcome Measures in Pulmonary Arterial Hypertension.
    Minhas J; Shou H; Hershman S; Zamanian R; Ventetuolo CE; Bull TM; Hemnes A; Chakinala MM; Mathai S; Al-Naamani N; Ellenberg S; Matura LA; Kawut SM; Shcherbina A
    Ann Am Thorac Soc; 2022 Apr; 19(4):572-582. PubMed ID: 34473938
    [No Abstract]   [Full Text] [Related]  

  • 4. Counting Steps: A New Way to Monitor Patients with Pulmonary Arterial Hypertension.
    Sehgal S; Chowdhury A; Rabih F; Gadre A; Park MM; Li M; Wang X; Highland KB;
    Lung; 2019 Aug; 197(4):501-508. PubMed ID: 31144016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.
    Miyamoto S; Nagaya N; Satoh T; Kyotani S; Sakamaki F; Fujita M; Nakanishi N; Miyatake K
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):487-92. PubMed ID: 10673190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.
    Saxer S; Lichtblau M; Berlier C; Hasler ED; Schwarz EI; Ulrich S
    Lung; 2019 Oct; 197(5):617-625. PubMed ID: 31263960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Patients With Pulmonary Hypertension: A Pilot Study.
    Rosenzweig E; Villeda GAV; Crook S; Koli F; Rosenzweig EB; Krishnan US
    Tex Heart Inst J; 2023 Oct; 50(5):. PubMed ID: 37853911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an Outpatient Service Rehabilitation Programme in Patients Affected by Pulmonary Arterial Hypertension: An Observational Study.
    Bussotti M; Gremigni P; Pedretti RFE; Kransinska P; Di Marco S; Corbo P; Marchese G; Totaro P; Sommaruga M
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(1):3-10. PubMed ID: 27908251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A predictive model of the effects of depression, anxiety, stress, 6-minute-walk distance, and social support on health-related quality of life in an adult pulmonary hypertension population.
    Tartavoulle TM
    Clin Nurse Spec; 2015; 29(1):22-8. PubMed ID: 25469437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Hemodynamic Profile, Physical Capacity and Quality of Life in Pulmonary Hypertension.
    Torres Dde F; Zin WA; Lopes AJ; Vigário Pdos S; Garcia MI; Waetge D; Bandeira ML; Bessa LG; Guimarães FS
    Arq Bras Cardiol; 2015 May; 104(5):387-93. PubMed ID: 25742419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac Effort to Compare Clinic and Remote 6-Minute Walk Testing in Pulmonary Arterial Hypertension.
    Lachant D; Kennedy E; Derenze B; Light A; Lachant M; White RJ
    Chest; 2022 Dec; 162(6):1340-1348. PubMed ID: 35777448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial.
    Souza R; Channick RN; Delcroix M; Galiè N; Ghofrani HA; Jansa P; Le Brun FO; Mehta S; Perchenet L; Pulido T; Sastry BKS; Sitbon O; Torbicki A; Rubin LJ; Simonneau G
    PLoS One; 2018; 13(3):e0193226. PubMed ID: 29590122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life of patients with pulmonary arterial hypertension associated with CHD: the multicentre cross-sectional ACHILLE study.
    Amedro P; Basquin A; Gressin V; Clerson P; Jais X; Thambo JB; Guerin P; Cohen S; Bonnet D
    Cardiol Young; 2016 Oct; 26(7):1250-9. PubMed ID: 26980152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension.
    Hoeper MM; Badesch DB; Ghofrani HA; Gibbs JSR; Gomberg-Maitland M; McLaughlin VV; Preston IR; Souza R; Waxman AB; Grünig E; Kopeć G; Meyer G; Olsson KM; Rosenkranz S; Xu Y; Miller B; Fowler M; Butler J; Koglin J; de Oliveira Pena J; Humbert M;
    N Engl J Med; 2023 Apr; 388(16):1478-1490. PubMed ID: 36877098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and psychological variables both affect daily physical activity in COPD: a structural equations model.
    Altenburg WA; Bossenbroek L; de Greef MH; Kerstjens HA; ten Hacken NH; Wempe JB
    Respir Med; 2013 Nov; 107(11):1740-7. PubMed ID: 23810269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARC-F scores can predict health status and daily activity in patients with idiopathic pulmonary fibrosis.
    Ohkubo H; Fujita K; Nakano A; Amakusa Y; Mori Y; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A
    J Thorac Dis; 2022 Nov; 14(11):4309-4318. PubMed ID: 36524076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between requirement to stop during a six-minute walk test and health-related quality of life, physical activity and physical performance amongst people with intermittent claudication.
    Golledge J; Yip L; Fernando ME; Pinchbeck J; Rowbotham S; Jenkins J; Leicht A
    Ann Vasc Surg; 2021 Oct; 76():363-369. PubMed ID: 33905859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the 6-minute walk test in hospitalized COPD patients exclusively correlate with lung function parameters or should psychological factors also be taken into account?
    Borgmann M; Ivanda M; Hadizamani Y; Mohaupt M; Bals R; Lucas R; Hamacher J; Köllner V
    PLoS One; 2020; 15(5):e0232587. PubMed ID: 32365134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
    Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
    Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.